Literature DB >> 17895415

The socioeconomic impact among Egyptian glaucoma patients.

Mohamed Eldaly1, Mostafa Hunter, Mohamed Khafagy.   

Abstract

BACKGROUND/AIM: To evaluate the economic burden of intraocular pressure (IOP)-lowering medications on Egyptian patients with glaucoma, in addition to studying the social grounds of glaucoma education.
METHODS: In a cross-sectional observational study, the clinical and socioeconomic data were collected from 68 glaucomatous patients who were attending the outpatient clinics of Cairo University Hospital, through interviews, questionnaires, and clinical examinations.
RESULTS: Patients had a mean IOP of 22.9 mm Hg (SD 11.5). Just under half the patients had an IOP of over 30 mmHg although 88% were on medical treatment; average of 2.1 medications (SD 0.8). Patients had been spending 79.5 LE (SD 95.3) on glaucoma medications a month, which equals 30.1% of their monthly income. Forty per cent of patients did not know that glaucoma causes blindness. The primary source of knowledge about glaucoma for 79.4% of patients was the ophthalmologist.
CONCLUSION: The lack of control of IOP is probably related to the economic burden associated with glaucoma medications. 'Glaucoma education' is an important issue to both the treating ophthalmologist and the patient.

Entities:  

Mesh:

Year:  2007        PMID: 17895415      PMCID: PMC2001016          DOI: 10.1136/bjo.2006.111757

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN: 0007-1161            Impact factor:   4.638


  9 in total

1.  Comment on 'What is the direct cost of treatment of acute primary angle closure glaucoma? The Singapore model'.

Authors:  Daya Papalkar; Ian C Francis; Ridia Lim
Journal:  Clin Exp Ophthalmol       Date:  2005-08       Impact factor: 4.207

2.  Worldwide glaucoma through the looking glass.

Authors:  R R A Bourne
Journal:  Br J Ophthalmol       Date:  2006-03       Impact factor: 4.638

3.  Deprivation and late presentation of glaucoma: case-control study.

Authors:  S Fraser; C Bunce; R Wormald; E Brunner
Journal:  BMJ       Date:  2001-03-17

4.  A multicenter, retrospective pilot study of resource use and costs associated with severity of disease in glaucoma.

Authors:  Paul P Lee; John G Walt; John J Doyle; Sameer V Kotak; Stacy J Evans; Donald L Budenz; Philip P Chen; Anne L Coleman; Robert M Feldman; Henry D Jampel; L Jay Katz; Richard P Mills; Jonathan S Myers; Robert J Noecker; Jody R Piltz-Seymour; Robert R Ritch; Paul N Schacknow; Janet B Serle; Gary L Trick
Journal:  Arch Ophthalmol       Date:  2006-01

5.  Causes of blindness and needs of the blind in Mansoura, Egypt.

Authors:  A H el-Gilany; S el-Fedawy; M Tharwat
Journal:  East Mediterr Health J       Date:  2002-01       Impact factor: 1.628

6.  Lifetime visual prognosis for patients with primary open-angle glaucoma.

Authors:  G S Ang; T Eke
Journal:  Eye (Lond)       Date:  2006-02-17       Impact factor: 3.775

7.  Estimated comparative costs of achieving a 20% reduction in intraocular pressure with bimatoprost or latanoprost in patients with glaucoma or ocular hypertension.

Authors:  Richard Fiscella; John Walt
Journal:  Drugs Aging       Date:  2006       Impact factor: 3.923

8.  Rate of progression in open-angle glaucoma estimated from cross-sectional prevalence of visual field damage.

Authors:  H A Quigley; J M Tielsch; J Katz; A Sommer
Journal:  Am J Ophthalmol       Date:  1996-09       Impact factor: 5.258

9.  Socioeconomic status, systolic blood pressure and intraocular pressure: the Tanjong Pagar Study.

Authors:  J L Y Yip; T Aung; T-Y Wong; D Machin; P T Khaw; K-T Khaw; S Seah; P J Foster
Journal:  Br J Ophthalmol       Date:  2006-08-23       Impact factor: 4.638

  9 in total
  4 in total

1.  Prevalence and determinants of glaucoma in citizens of qatar aged 40 years or older: a community-based survey.

Authors:  Fatma A Al-Mansouri; Aida Kanaan; Hamad Gamra; Rajiv Khandekar; Shakeel P Hashim; Omar Al Qahtani; Mohd Farouk Ahmed
Journal:  Middle East Afr J Ophthalmol       Date:  2011-04

2.  Analysis of Factors Affecting Patients' Compliance to Topical Antiglaucoma Medications in Egypt as a Developing Country Model.

Authors:  Nahla B Abu Hussein; Iman M Eissa; Ahmed A Abdel-Kader
Journal:  J Ophthalmol       Date:  2015-06-17       Impact factor: 1.909

3.  Blindness and Visual Impairment among Egyptian Glaucoma Patients.

Authors:  M A Eldaly; M M Salama; K G Abu Eleinen; D Ghalwash; M Youssef; A F El-Shiaty
Journal:  J Ophthalmol       Date:  2014-01-29       Impact factor: 1.909

4.  So let me find my way, whatever it will cost me, rather than leaving myself in darkness: experiences of glaucoma in Nigeria.

Authors:  Fatima Kyari; Clare I Chandler; Martha Martin; Clare E Gilbert
Journal:  Glob Health Action       Date:  2016-12-06       Impact factor: 2.640

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.